Q4 2024 · 13F-HR
AJU IB Investment Co., Ltd.holdings as filed
Filed 2025-04-08 · accession 0001140361-25-012673
$102.8M
Reported value
8
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $80.3M | 78.2% | 1,047,557 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $18.4M | 17.9% | 457,059 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $1.9M | 1.84% | 816,375 | Common | SOLE |
| 75120L100 | — | RALLYBIO CORP | $724,491 | 0.71% | 754,678 | Common | SOLE |
| 98422T100 | — | XILIO THERAPEUTICS INC | $637,694 | 0.62% | 667,742 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $322,000 | 0.31% | 175,000 | Common | SOLE |
| 14216R101 | CARM | CARISMA THERAPEUTICS INC | $300,837 | 0.29% | 718,332 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $157,215 | 0.15% | 99,503 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.